<DOC>
	<DOC>NCT02117687</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of OPTIVE FUSION™ compared to VISMED® Multi for the management of dry eye.</brief_summary>
	<brief_title>A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Use of artificial tears for dry eye in both eyes for at least 3 months Use of preservativefree artificial tears at least twice daily for 2 weeks; Cataract, laserassisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK) surgery in the last 12 months Use of punctal plugs or contact lenses in the last month Active ocular allergy within last 2 years Best corrected visual acuity (BCVA) less than 20/200 in either eye</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>